Related Experiment Video
Updated: Jul 13, 2026
One-anastomosis Gastric Bypass (OAGB) in Rats
Published on: November 10, 2018
Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium- and long-term
M Korenkov1, S Shah, S Sauerland
1Department of Surgery, University of Mainz, Germany. korenkov@ach.klinik.uni-mainz.de
Background:
The authors evaluated the impact of laparoscopic adjustable gastric banding (LAGB) on obesity-associated diseases in a series at 3 to 8 years postoperatively, namely diabetes, pulmonary disease, hypertension and knee joint pain.
Methods:
145 morbidly obese patients underwent LAGB with mean age 38 years and preoperative BMI 48.5 kg/m2 (range 34-77). Changes in BMI and excess BMI loss (EBL) were evaluated.
Results:
138 of the 145 patients (95%) were available for full follow-up. At last follow-up, BMI had dropped to 34.0 +/- 6.4 SD kg/m2, and mean EBL was 61.9 +/- 26.1%. Prevalence of obesity-associated disease was significantly reduced: diabetes decreased from 10% to 4%, treatment-requiring pulmonary disease from 15% to 5%, hypertension from 43% to 27%, and knee pain from 47% to 38%.
Conclusion:
Following gastric banding, >75% of patients suffering from obesity-related disease had significant decrease or resolution of their co-morbidities.
